Quality risk management adopted from ICH Q9
Ergopharm has adopted the quality risk management framework described in ICH Q9 as the formal basis for deciding how much validation, sampling and control a given process or change requires.
Before Q9, decisions about how thoroughly to validate something were made by experience and argument. The guideline provides a structure: identify what could go wrong, judge how likely it is and how bad it would be, decide what control is proportionate, and record the reasoning so that the next person can see why the decision was made.
“Risk management did not reduce the work. It moved the work to the steps that could actually hurt a patient.”
In practice this changed the shape of protocols. A high-risk step — an aseptic intervention, a cleaning changeover between products — attracts more sampling and tighter acceptance criteria; a low-risk step attracts less. The total effort did not fall, but it moved to where it mattered.
The framework was later restated as ICH Q9(R1), which added guidance on subjectivity in risk assessment and on formality; the site's procedures reference the current revision.
Key facts
- Framework
- ICH Q9 quality risk management
- Applied to
- Validation scope, sampling, change evaluation
- Principle
- Effort proportionate to risk, reasoning recorded
- Current revision
- ICH Q9(R1)
This notice describes Ergopharm’s own packaging and processes and how they follow published standards; it does not assert a specific national marketing approval.